Evidence supporting the use of: Nitrates
For the health condition: Congestive Heart Failure

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Nitrates are used in the management of congestive heart failure (CHF), particularly in acute decompensated heart failure and in patients with associated myocardial ischemia. The scientific rationale for their use is well-established: nitrates act as vasodilators, primarily by releasing nitric oxide, which relaxes vascular smooth muscle. This leads to venodilation (reduction in preload) and, at higher doses, some arterial dilation (reduction in afterload). By reducing preload and afterload, nitrates decrease the workload on the failing heart and lower myocardial oxygen demand, which is especially beneficial in patients with concurrent angina or ischemic heart disease.

Clinical guidelines, such as those from the American Heart Association (AHA) and European Society of Cardiology (ESC), include intravenous nitrates (e.g., nitroglycerin) as options for symptomatic relief of dyspnea in acute heart failure, particularly with elevated blood pressure or ischemic symptoms. However, the evidence for their use in chronic, stable heart failure is less robust, and they are not considered first-line therapy for long-term management. Meta-analyses and randomized controlled trials have shown nitrates can provide symptomatic improvement and hemodynamic benefits, but their impact on long-term mortality and outcomes is limited compared to other agents such as ACE inhibitors and beta-blockers.

In summary, the use of nitrates in CHF is scientifically validated for acute symptom relief and hemodynamic management, especially when ischemia is present, but they play a limited role in chronic heart failure treatment.

More about Nitrates
More about Congestive Heart Failure

Products containing Nitrates

We currently have no products on Caring Sunshine that contain this ingredient.